MAGEA6 Engages a YY1-Dependent Transcription to Dictate Perineural Invasion in Colorectal Cancer

  • 0Department of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200092, P. R. China.

Summary

This summary is machine-generated.

MAGEA6 drives colorectal cancer (CRC) nerve invasion by recruiting Schwann cells. Inhibiting MAGEA6 may offer a new therapeutic strategy for treating advanced CRC and improving patient prognosis.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cancer Research

Background

  • Perineural invasion (PNI) in colorectal cancer (CRC) is linked to poor patient outcomes.
  • Understanding the molecular mechanisms driving PNI is essential for developing novel therapeutic strategies.

Purpose Of The Study

  • To investigate the role of MAGEA6 in colorectal cancer perineural invasion.
  • To elucidate the molecular mechanisms by which MAGEA6 influences PNI and tumor progression.

Main Methods

  • Analysis of TCGA database for clinical and transcriptome data.
  • Generation of MAGEA6 knockdown CRC cell lines and assessment of invasion.
  • Utilized rectal orthotopic and sciatic nerve invasion models.
  • Investigated Schwann cell recruitment via ssGSEA and co-culture experiments.

Main Results

  • MAGEA6 expression correlates with poor prognosis in CRC patients.
  • MAGEA6 knockdown significantly reduces CRC cell migration, invasion, and PNI.
  • CRC cells recruit Schwann cells (SCs) through CXCL1, a process promoted by MAGEA6.
  • MAGEA6 stabilizes YY1, enhancing CXCL1 transcription and subsequent SC recruitment.

Conclusions

  • MAGEA6 is a key regulator of PNI in colorectal cancer.
  • MAGEA6 promotes CRC invasiveness and PNI by stabilizing YY1, leading to increased CXCL1 secretion and SC recruitment.
  • Targeting MAGEA6 represents a potential therapeutic avenue for managing PNI in CRC.